- Home
- NVRO
NVRO
Nevro Corp.
as 02-21-2025 4:00pm EST
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
Upcoming Earnings Alert:
Get ready for potential market movements as Nevro Corp. NVRO prepares to release earnings report on 28 Feb 2025.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 214.2M | IPO Year: | 2014 |
| Target Price: | $7.24 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Hold | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.17 - $16.79 | Next Earning Date: | 02-28-2025 |
| Revenue: | $419,146,000 | Revenue Growth: | -0.87% |
| Revenue Growth (this year): | -2.79% | Revenue Growth (next year): | 0.23% |
Latest Nevro Corp. News
NVRO Breaking Stock News: Dive into NVRO Ticker-Specific Updates for Smart Investing
GuruFocus.com
2 days ago
Globus Medical Inc (GMED) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...
Zacks
9 days ago
Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth
Zacks
10 days ago
Nevro (NVRO) Expected to Beat Earnings Estimates: Should You Buy?
Zacks
11 days ago
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?
Medical Device Network
12 days ago
Globus Medical strengthens SCS market position with $250m Nevro deal
MT Newswires
12 days ago
Jefferies Upgrades Nevro to Hold From Underperform, Adjusts Price Target to $5.85 From $4.50
Zacks
15 days ago
Nevro (NVRO) Upgraded to Buy: What Does It Mean for the Stock?
TipRanks
15 days ago
Globus Medical to acquire Nevro for $5.85 per share
Compare NVRO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NVRO Nevro Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.